Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch–Schönlein purpura nephritis

Addition of Plasma Exchange to Glucocorticosteroids for the Treatment of Severe Henoch-Schönlein Purpura in Adults: A Case Series

(2012) Jean-François Augusto et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset

(2012) Outi Jauhola et al.   PEDIATRIC NEPHROLOGY

Chapter 11: Henoch-Schönlein purpura nephritis

(2012)   Kidney International Supplements

Henoch-Schonlein Purpura Nephritis: Pathophysiology, Treatment, and Future Strategy

(2011) J.-C. Davin   Clinical Journal of the American Society of Nephrology

Treatment strategies for Henoch-Schönlein purpura nephritis by histological and clinical severity

(2011) Takeshi Ninchoji et al.   PEDIATRIC NEPHROLOGY

Cyclosporine A vs. methylprednisolone for Henoch–Schönlein nephritis: a randomized trial

(2011) Outi Jauhola et al.   PEDIATRIC NEPHROLOGY

Methylprednisolone pulse plus mizoribine in children with Henoch–Schoenlein purpura nephritis

(2010) Yukihiko Kawasaki et al.   CLINICAL RHEUMATOLOGY

Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura

(2010) Evangéline Pillebout et al.   KIDNEY INTERNATIONAL

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification

(2009) Daniel C. Cattran et al.   KIDNEY INTERNATIONAL

Early high-dose immunosuppression in Henoch–Schönlein nephrotic syndrome may improve outcome

(2009) R. F. Andersen et al.   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

(2008) Christian Faul et al.   NATURE MEDICINE